The Healthcare Venture Fund invests in transformative Canadian companies that will dramatically increase healthcare productivity by reducing healthcare costs while improving patient health.
Our experienced team manages $270 million in capital across two different funds. The team is currently seeking investments in the drug, devices, diagnostics and digital health sectors.
Please send us your business plan at email@example.com
Profound Medical Corp. (“Profound” or “Company”) (TSXV:PRN), a medical device company commercializing a unique and minimally invasive therapy in prostate care, today announced that the company has received CE Mark approval for the commercial sale of TULSA-PROTM.
View all news
Milestone Pharmaceuticals Inc., a clinical stage cardiovascular company in Phase 2, today announced the close of a US$17 million Series B financing.
Senior Managing Partner
Subscribe to receive, via email, tips, articles and tools for entrepreneurs and more information about our solutions and events. You can withdraw your consent at any time.